Bangladesh · Delayed Price · Currency is BDT Ambee Pharmaceuticals Statistics
Total Valuation
DSE:AMBEEPHA has a market cap or net worth of BDT 1.83 billion. The enterprise value is 2.39 billion.
| Market Cap | 1.83B |
| Enterprise Value | 2.39B |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DSE:AMBEEPHA has 2.40 million shares outstanding.
| Current Share Class | 2.40M |
| Shares Outstanding | 2.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 77.25% |
| Owned by Institutions (%) | n/a |
| Float | 545,941 |
Valuation Ratios
The trailing PE ratio is 331.51.
| PE Ratio | 331.51 |
| Forward PE | n/a |
| PS Ratio | 11.63 |
| PB Ratio | 51.82 |
| P/TBV Ratio | 51.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 433.29 |
| EV / Sales | 15.20 |
| EV / EBITDA | 267.80 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 18.68.
| Current Ratio | 0.85 |
| Quick Ratio | 0.44 |
| Debt / Equity | 18.68 |
| Debt / EBITDA | 73.85 |
| Debt / FCF | -35.88 |
| Interest Coverage | 119.99 |
Financial Efficiency
Return on equity (ROE) is 16.36% and return on invested capital (ROIC) is 0.50%.
| Return on Equity (ROE) | 16.36% |
| Return on Assets (ROA) | 0.34% |
| Return on Invested Capital (ROIC) | 0.50% |
| Return on Capital Employed (ROCE) | 10.41% |
| Weighted Average Cost of Capital (WACC) | 2.14% |
| Revenue Per Employee | 332,515 |
| Profits Per Employee | 11,661 |
| Employee Count | 474 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.36 |
Taxes
In the past 12 months, DSE:AMBEEPHA has paid 2.10 million in taxes.
| Income Tax | 2.10M |
| Effective Tax Rate | 27.49% |
Stock Price Statistics
The stock price has decreased by -0.87% in the last 52 weeks. The beta is -0.24, so DSE:AMBEEPHA's price volatility has been lower than the market average.
| Beta (5Y) | -0.24 |
| 52-Week Price Change | -0.87% |
| 50-Day Moving Average | 766.62 |
| 200-Day Moving Average | 771.92 |
| Relative Strength Index (RSI) | 46.41 |
| Average Volume (20 Days) | 1,636 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:AMBEEPHA had revenue of BDT 157.61 million and earned 5.53 million in profits. Earnings per share was 2.30.
| Revenue | 157.61M |
| Gross Profit | 72.95M |
| Operating Income | 4.06M |
| Pretax Income | 7.62M |
| Net Income | 5.53M |
| EBITDA | 8.50M |
| EBIT | 4.06M |
| Earnings Per Share (EPS) | 2.30 |
Balance Sheet
The company has 97.86 million in cash and 660.41 million in debt, with a net cash position of -562.54 million or -234.39 per share.
| Cash & Cash Equivalents | 97.86M |
| Total Debt | 660.41M |
| Net Cash | -562.54M |
| Net Cash Per Share | -234.39 |
| Equity (Book Value) | 35.36M |
| Book Value Per Share | 14.73 |
| Working Capital | -110.21M |
Cash Flow
In the last 12 months, operating cash flow was -18.41 million and capital expenditures 254, giving a free cash flow of -18.41 million.
| Operating Cash Flow | -18.41M |
| Capital Expenditures | 254 |
| Depreciation & Amortization | 4.44M |
| Net Borrowing | 36.28M |
| Free Cash Flow | -18.41M |
| FCF Per Share | -7.67 |
Margins
Gross margin is 46.28%, with operating and profit margins of 2.57% and 3.51%.
| Gross Margin | 46.28% |
| Operating Margin | 2.57% |
| Pretax Margin | 4.84% |
| Profit Margin | 3.51% |
| EBITDA Margin | 5.39% |
| EBIT Margin | 2.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.37% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.13% |
| Earnings Yield | 0.30% |
| FCF Yield | -1.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 29, 2014. It was a forward split with a ratio of 1.2.
| Last Split Date | May 29, 2014 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
DSE:AMBEEPHA has an Altman Z-Score of 1.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.63 |
| Piotroski F-Score | 2 |